Summary

Yumanity Therapeutics

Founded in 2014

Description

Yumanity Therapeutics is a biotechnology company that is focused on transforming drug discovery for neurodegenerative diseases caused by protein misfolding.

Strengths

  • Yumanity Therapeutics has a strong market share in their industry
  • Revenue generated per employee is greater than industry average
  • Demonstrating revenue growth that is faster than the industry average
  • Since Yumanity Therapeutics was founded, the company has grown faster than the industry average

Weaknesses

  • The number of employees is not growing as fast as the industry average
  • Variance of revenue growth is more than the industry average

Annual Revenue

Yumanity Therapeutics's annual revenue

$5535000

Based on Kona Equity data

  • Revenue per employee

    $138375

  • Variance of revenue growth

    1.87

  • Annual revenue growth since founding

    $2592500

  • Revenue growth rate from first known quarter to current

    172.9%

Employee Count

40 employees

  • Employee growth rate from first known quarter to current

    15.8%

Executives

Bertrand Bourdonnec

Vice President, Medicinal Chemistry & Program Management

b**@yumanity.com

G Score - 4

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G1 Revenue is greater than the industry median.
  • G2 Income per employee more than industry average.
  • G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
  • G6 Annual revenue growth since founding is higher than the industry average.

Location

790 Memorial Dr., Ste. 2C 2C
Cambridge, MA  02139

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Similar Companies

Cognition Therapeutics

cogrx.com
  • Founded in 2007
  • Location: Pittsburgh, PA
  • Annual Revenue: $2.8M
  • Employees: 19
  • Cognition Therapeutics is a clinical stage neuroscience company that develops innovative small molecule therapeutics to treat age-related degenerative diseases of the central nervous system (CNS) and retina. Their lead product candidate, CT1812, has sh...

Alkahest Inc

alkahest.com
  • Founded in 2014
  • Location: San Carlos, CA
  • Annual Revenue: $17.6M
  • Employees: 44
  • Alkahest is a clinical stage biopharmaceutical company focused on treating neurodegenerative and other age-related diseases. They develop transformative therapies derived from a deep understanding of the plasma proteome in aging and disease. Their rese...

Neuraltus Pharmaceuticals

neuraltus.com
  • Founded in 2004
  • Location: San Bruno, CA
  • Annual Revenue: $3.5M
  • Employees: 18

Alzheon

alzheon.com
  • Founded in 2013
  • Location: Framingham, MA
  • Annual Revenue: $3.8M
  • Employees: 16
  • Alzheon is committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.

Apexigen Inc

apexigen.com
  • Location: San Carlos, CA
  • Annual Revenue: $4.2M
  • Employees: 20
  • Apexigen is a biopharmaceutical product development company developing products to address life-threatening and difficult to treat diseases.

Leap Therapeutics

leaptx.com
  • Founded in 2016
  • Location: Cambridge, MA
  • Annual Revenue: $1.1M
  • Employees: 36
  • Leap Therapeutics, Inc. (Nasdaq: LPTX) is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer patients. Their most advanced clinical candidate, DKN 01, is a humanized monoclonal antibody...

Key Information

  • SIC: 87; 873
  • NAICS: 32541; 5417
Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with Yumanity Therapeutics.

See similar companies

Frequently Asked Questions

Where is Yumanity Therapeutics located?

Yumanity Therapeutics's headquarters are located at 790 Memorial Dr., Ste. 2C 2C Cambridge, MA  02139.


What is Yumanity Therapeutics's official website?

Yumanity Therapeutics's official website is yumanity.com


What is Yumanity Therapeutics's revenue?

Yumanity Therapeutics's annual revenue is $5.5 M.


What is Yumanity Therapeutics's SIC code?

Yumanity Therapeutics's SIC: 87; 873


What is Yumanity Therapeutics's NAICS code?

Yumanity Therapeutics's NAICS: 32541; 5417.


How many employees does Yumanity Therapeutics's have?

Yumanity Therapeutics has 40 employees


What industry does Yumanity Therapeutics belong to?

Yumanity Therapeutics is in the industry of Biotechnology.

Next step

Visitors review